Work

Aromatase inhibitors in breast cancer.

Year: 2024

Type: article

Abstract: This article discusses the role of aromatase in estrogen synthesis and its implications for breast cancer treatment. Aromatase is an enzyme that converts androgens into estrogens, and its expression is regulated by various factors, including gonadotropins and obesity-related inflammation. The article also explores the mechanisms and efficacy of aromatase inhibitors, such as anastrozole, letrozole, and exemestane, which are used to treat estrogen receptor-positive breast cancer.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.14537064

Author: Makedonskaia, Sofiia

Institution: American Association of Gynecologic Laparoscopists

Language: English

Topic: Estrogen and related hormone effects

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6930742646

FWCI:

Cites:

Cited by:

Related to: